Clinical Trial

Impact of Medications Review on Potentially Inappropriate Medications and Clinical Outcomes Among Hospitalized Older Adults

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 8, 2025 (before its estimated August 28, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this randomized controlled trial is to assess the effectiveness of a pharmacist-led medication review using the locally developed Malaysian Potentially Inappropriate Prescribing Screening tool in Older Adults (MALPIP), an explicit criteria in hospitalized older adults. The main questions it aims to answer are: 1. The effectiveness of the intervention in reducing the number of PIMs and chronic medications after discharge 2. The impact of the intervention on quality of life, falls events, emergency department visits, readmissions and survivals Researchers will compare the control group to see if there is corresponding changes to the outcomes specified above.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-05-16; most recent amendment 2025-05-05.
Status change: Recruiting → Active, Not Recruiting 2024-11-19
Status change: Not Yet Recruiting → Recruiting 2023-10-17
Trial Details
NCT Number NCT05875623
Lead Sponsor Monash University
Collaborators: Hospital Raja Permaisuri Bainun
Conditions Deprescriptions, Aged, Inappropriate Prescribing, Potentially Inappropriate Medications, Polypharmacy
Enrollment 500 participants
Start Date 2023-07-06
Primary Completion 2025-08-28 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-05-08